首页 | 本学科首页   官方微博 | 高级检索  
检索        

HPLC-MS/MS测定人血浆中妥舒沙星的浓度
引用本文:邹尚荣,王明礼,尚德为,张明,倪晓佳,叶林淼,温预关.HPLC-MS/MS测定人血浆中妥舒沙星的浓度[J].中国现代应用药学,2014,31(7):846-850.
作者姓名:邹尚荣  王明礼  尚德为  张明  倪晓佳  叶林淼  温预关
作者单位:广州市第八人民医院药剂科,广州 510060;广州市第八人民医院药剂科,广州 510060;广州医科大学附属广州市脑科医院,广州 510370;广州医科大学附属广州市脑科医院,广州 510370;广州医科大学附属广州市脑科医院,广州 510370;安徽医科大学,合肥 230032;广州医科大学附属广州市脑科医院,广州 510370
基金项目:广东省医学科研基金(A2013523);广东省自然科学基金面上项目(8151037001000001)
摘    要:目的 建立快速、灵敏测定人体血浆中妥舒沙星浓度的高效液相色谱-串联质谱方法。方法 采用Agilent EclipsePlus C18色谱柱(4.6 mm×150 mm,3.5μm),乙腈(含0.1%甲酸)-5 mmol.L 1甲酸铵水溶液(36∶64)为流动相等度洗脱,流速为0.5 mL.min 1,柱温40℃。采用多重反应监测(MRM)对妥舒沙星(m/z 405.2→387.2)和内标环丙沙星(m/z 332.2→314.2)的测定。结果 妥舒沙星的线性范围为6-2 000 ng.mL 1,回归方程为y=0.183 5x+1.461 9×10 4,r=0.996 2,最低定量下限为6 ng.mL 1(S/N〉5),日内、日间RSD均〈10%,高(1 800 ng.mL 1)、中(750 ng.mL 1)、低(15 ng.mL 1)浓度标准血样的平均回收率分别为97.5%,103.3%,105.9%。结论 该方法灵敏、准确、简单、快速,可用于妥舒沙星的临床血药浓度监测和药动学研究。

关 键 词:妥舒沙星  血药浓度  高效液相色谱-串联质谱法
收稿时间:2013/10/21 0:00:00
修稿时间:2014/6/30 0:00:00

Determination of Tosufloxacin in Plasma by HPLC-MS/MS
ZOU Shangrong,WANG Mingli,SHANG Dewei,ZHANG Ming,NI Xiaoji,YE Linmiao and WEN Yuguan.Determination of Tosufloxacin in Plasma by HPLC-MS/MS[J].The Chinese Journal of Modern Applied Pharmacy,2014,31(7):846-850.
Authors:ZOU Shangrong  WANG Mingli  SHANG Dewei  ZHANG Ming  NI Xiaoji  YE Linmiao and WEN Yuguan
Institution:ZOU Shangrong, WANG Mingli, SHANG Dewei, ZHANG Ming, NI Xiaojia, YE Linmiao, WEN Yuguan (1.Department of Pharmacy, Guangzhou Eighth People's Hospital, Guangzhou 510060, China," 2.Guangzhou Brain Hospital, Guangzhou Medical University, Guangzhou 510370, China, 3.Anhui Medical University, Hefei 230032, China)
Abstract:OBJECTIVE To establish a rapid and sensitive HPLC-MS/MS method for tosufloxacin in plasma. METHODS Tosufloxacin was extracted with acetonitrile and the residues were analyzed with a HPLC-MS/MS system used Agilent Eclipse Plus Cl8 column(4.6 mm× 150 mm, 3.5 min) with the mobile phase consisted of acetonitrile (0.1% formic acid) with 5 mmol'L-1 ammonium formate(36 : 64), with a flow rate of 0.5 mL·min-1 and temperature of 40℃. Multiple reaction monitoring(MRM) using the precursor to production combinations of m/z 405.2→387.2 and m/z 332.2→314.2 was performed to detect tosufloxacin and the internal standard, respectively. RESULTS The calibration curves for tosufloxacin had good linearity within the range of 6-2 000 ng·mL-1, r=0.996 2. The limits of quantitation for tosufloxacin was 6 ng.mL 1. The intra-day and inter-day precision of variation was 〈10%. The average recoveries for high-, middle-, low-dose of tosufloxacin(1 800, 750, 15 ng·mL-1) were 97.5%, 103.3% and 105.9%, respectively. CONCLUSION The method provides a sensitive, accurate, precise and reliable analytical procedure for clinical monitoring oftosufloxacin plasma and its pharmacokinetic studies.
Keywords:tosufloxacin  plasma concentration  HPLC-MS/MS
本文献已被 维普 等数据库收录!
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号